Correlation Between Virpax Pharmaceuticals and Cocrystal Pharma

Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virpax Pharmaceuticals and Cocrystal Pharma, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Cocrystal Pharma.

Diversification Opportunities for Virpax Pharmaceuticals and Cocrystal Pharma

0.12

Correlation Coefficient

Virpax Pharmaceuticals  Cocrystal Pharma

Average diversification

The 3 months correlation between Virpax and Cocrystal is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Virpax Pharmaceuticals and Cocrystal Pharma

Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Virpax Pharmaceuticals is 1.05 times less risky than Cocrystal Pharma. The stock trades about -0.09 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  205.00  in Cocrystal Pharma on December 2, 2024 and sell it today you would lose (32.00) from holding Cocrystal Pharma or give up 15.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Virpax Pharmaceuticals  vs.  Cocrystal Pharma

Virpax Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Virpax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cocrystal Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cocrystal Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Cocrystal Pharma is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Virpax Pharmaceuticals and Cocrystal Pharma

The main advantage of trading using opposite Virpax Pharmaceuticals and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.

The idea behind Virpax Pharmaceuticals and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.